Albert David

{
  "main_header": {
    "sid": 876497,
    "name": "Albert David",
    "stock_name": "Albert David",
    "full_name": "Albert David Ltd",
    "name_url": "stocks-analysis/albert-david",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "658.50",
    "chg": -12.85,
    "chgp": "-1.91%",
    "dir": -1,
    "prev_price": "671.35",
    "mcapval": "383.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524075,
    "symbol": "ALBERTDAVD",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE155C01010",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": "3.93 k",
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/albert-david-876497-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Albert David Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-sell-3904951",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlbertDavidLtd_mojoScore_3904951.png",
        "date": "2026-03-21 10:10:13",
        "description": "Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance."
      },
      {
        "title": "Albert David Ltd Stock Falls to 52-Week Low of Rs.601",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-ltd-stock-falls-to-52-week-low-of-rs601-3893715",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlbertDavidLtd_priceRelatedfactors_3893715.png",
        "date": "2026-03-16 11:28:26",
        "description": "Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.601 today, marking a significant decline amid ongoing market headwinds and subdued financial performance over the past year."
      },
      {
        "title": "Albert David Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-sell-3882522",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlbertDavidLtd_mojoScore_3882522.png",
        "date": "2026-03-10 10:10:18",
        "description": "Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Albert David Ltd Falls to 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-ltd-falls-to-52-week-low-amid-continued-downtrend-3880200",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlbertDavidLtd_priceRelatedfactors_3880200.png",
        "date": "2026-03-09 13:30:06",
        "description": "Albert David Ltd’s share price declined sharply to a new 52-week low of Rs.645 on 9 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s shares have underperformed both the sector and broader market indices, reflecting persistent challenges in financial performance and market sentiment."
      },
      {
        "title": "Albert David Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-sell-3859981",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AlbertDavidLtd_mojoScore_3859981.png",
        "date": "2026-02-27 10:10:17",
        "description": "Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 February 2026, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Albert David Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-sell-3842347",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AlbertDavidLtd_mojoScore_3842347.png",
        "date": "2026-02-16 10:10:04",
        "description": "Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Are Albert David Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-albert-david-ltd-latest-results-good-or-bad-3835802",
        "imagepath": "",
        "date": "2026-02-12 19:54:13",
        "description": "Albert David Ltd's latest financial results indicate a challenging operational environment. In Q2 FY26, the company reported net sales of ₹87.24 crores, reflecting an 11.38% decline year-on-year, continuing a trend of revenue contraction over three consecutive quarters. Although there was a quarter-on-quarter improvement of 23.62% from a weak Q1 FY26, this recovery does not mitigate the broader concerns regarding the company's financial trajectory.\n\nThe net profit for Q2 FY26 was a loss of ₹3.30 crores, a significant reversal from the profit of ₹18.07 crores reported in the same quarter the previous year. This loss raises questions about the sustainability of the company's operations, especially as the operating margin, excluding other income, fell to just 2.91%, down from 6.33% year-on-year. Such a decline in margins suggests fundamental operational challenges, likely driven by pricing pressures and rising..."
      },
      {
        "title": "Albert David Q3 FY26: Profitability Crisis Deepens as Losses Mount",
        "link": "https://www.marketsmojo.com/news/result-analysis/albert-david-q3-fy26-profitability-crisis-deepens-as-losses-mount-3833873",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AlbertDavid_quaterlyResult_3833873.png",
        "date": "2026-02-11 20:06:45",
        "description": "Albert David Ltd., a Kolkata-based pharmaceutical manufacturer, reported a net loss of ₹3.30 crores in Q2 FY26 (Jul-Sep'25), marking a sharp reversal from the ₹18.07 crores profit posted in the same quarter last year—a staggering decline of 118.27% year-on-year. The loss comes despite a modest sequential recovery in the previous quarter, highlighting persistent operational challenges that have plagued the company throughout FY25 and into FY26."
      },
      {
        "title": "Albert David Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/albert-david-ltd-is-rated-strong-sell-3822284",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AlbertDavidLtd_mojoScore_3822284.png",
        "date": "2026-02-05 10:10:21",
        "description": "Albert David Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 May 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 05 February 2026, providing investors with the latest insights into its performance and prospects."
      }
    ],
    "total": 163,
    "sid": "876497",
    "stock_news_url": "https://www.marketsmojo.com/news/albert-david-876497"
  },
  "announcements": [
    {
      "details": "Albert David Limited has informed the Exchange regarding Disclosure of related party transactions for the half year ended on September 30, 2019.",
      "source": "NSE",
      "caption": "Albert David Limited - Other General Purpose",
      "datetime": "21-Nov-2019"
    },
    {
      "details": "Albert David Limited has informed the Exchange regarding a press release dated November 15, 2019, titled \"Extract of Unaudited Financial Results for the quarter and half year ended on 30th September, 2019\".",
      "source": "NSE",
      "caption": "Albert David Limited - Press Release",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Albert David Limited has informed the Exchange regarding Board meeting held on November 14, 2019 for approval of unaudited financial results for the quarter and half year ended 30th September, 2019. .",
      "source": "NSE",
      "caption": "Albert David Limited - Outcome of Board Meeting",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Albert David Ltd has declared <strong>50%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Albert David Ltd is Rated Sell

2026-03-21 10:10:13

Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

Read full news article

Albert David Ltd Stock Falls to 52-Week Low of Rs.601

2026-03-16 11:28:26

Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.601 today, marking a significant decline amid ongoing market headwinds and subdued financial performance over the past year.

Read full news article

Albert David Ltd is Rated Sell

2026-03-10 10:10:18

Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Albert David Ltd Falls to 52-Week Low Amid Continued Downtrend

2026-03-09 13:30:06

Albert David Ltd’s share price declined sharply to a new 52-week low of Rs.645 on 9 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s shares have underperformed both the sector and broader market indices, reflecting persistent challenges in financial performance and market sentiment.

Read full news article

Albert David Ltd is Rated Sell

2026-02-27 10:10:17

Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 February 2026, providing investors with an up-to-date view of its performance and outlook.

Read full news article

Albert David Ltd is Rated Sell

2026-02-16 10:10:04

Albert David Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Are Albert David Ltd latest results good or bad?

2026-02-12 19:54:13

Albert David Ltd's latest financial results indicate a challenging operational environment. In Q2 FY26, the company reported net sales of ₹87.24 crores, reflecting an 11.38% decline year-on-year, continuing a trend of revenue contraction over three consecutive quarters. Although there was a quarter-on-quarter improvement of 23.62% from a weak Q1 FY26, this recovery does not mitigate the broader concerns regarding the company's financial trajectory. The net profit for Q2 FY26 was a loss of ₹3.30 crores, a significant reversal from the profit of ₹18.07 crores reported in the same quarter the previous year. This loss raises questions about the sustainability of the company's operations, especially as the operating margin, excluding other income, fell to just 2.91%, down from 6.33% year-on-year. Such a decline in margins suggests fundamental operational challenges, likely driven by pricing pressures and rising...

Read full news article

Albert David Q3 FY26: Profitability Crisis Deepens as Losses Mount

2026-02-11 20:06:45

Albert David Ltd., a Kolkata-based pharmaceutical manufacturer, reported a net loss of ₹3.30 crores in Q2 FY26 (Jul-Sep'25), marking a sharp reversal from the ₹18.07 crores profit posted in the same quarter last year—a staggering decline of 118.27% year-on-year. The loss comes despite a modest sequential recovery in the previous quarter, highlighting persistent operational challenges that have plagued the company throughout FY25 and into FY26.

Read full news article

Albert David Ltd is Rated Strong Sell

2026-02-05 10:10:21

Albert David Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 May 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 05 February 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

View All News